OPKO Health, Inc. (OPK) Financials
OPK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.8 billion | 645.3 million |
| March 31, 2026 | 1.9 billion | 652.2 million |
| Dec. 31, 2025 | 1.9 billion | 664.0 million |
| Sept. 30, 2025 | 2.0 billion | 690.0 million |
OPK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -46.5 million | 2.2 million |
| March 31, 2026 | -21.1 million | 2.7 million |
| Dec. 31, 2025 | -28.6 million | 2.9 million |
| Sept. 30, 2025 | -37.8 million | 3.0 million |
OPK Net Income
No data available :(
OPK Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 300.8 million | 336.7 million | 45.0 million |
| March 31, 2026 | 341.9 million | 336.0 million | 51.3 million |
| Dec. 31, 2025 | 369.1 million | 370.5 million | 40.2 million |
| Sept. 30, 2025 | 415.2 million | 331.4 million | 51.2 million |
OPK Shares Outstanding
OPK Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 3.0 million | 33.2 million | 52.9 million | - |
| March 31, 2026 | 1.8 million | 29.2 million | 48.6 million | - |
| Dec. 31, 2025 | 2.7 million | 32.8 million | 50.5 million | - |
| Sept. 30, 2025 | 3.1 million | 30.1 million | 53.8 million | - |
OPK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 163.6 million | 83.6 million |
| March 31, 2026 | 124.2 million | 97.4 million |
| Dec. 31, 2025 | 148.5 million | 103.5 million |
| Sept. 30, 2025 | 151.7 million | 121.3 million |
OPK Revenue by Segment
Graph available only for paid members. Upgrade to see it.
OPK
Price: $1.64
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.07 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 3.2 million
Ebitda: -39.6 millionMarket Capitalization: 1.2 billion